Literature DB >> 23796303

Systematic searching and selection of health state utility values from the literature.

Diana Papaioannou1, John Brazier, Suzy Paisley.   

Abstract

Health state utility values (HSUVs) are important parameters in decision models in health technology assessment submissions. Reimbursement agencies, such as the National Institute for Health and Clinical Excellence, recognize that such values are obtainable from the published literature. However, to use published values in health technology assessment submissions, it should be demonstrated that HSUVs have been identified and selected systematically to avoid using biased HSUVs resulting in cost-effectiveness analyses. This article presents guidance on how to conduct a systematic literature review to identify and select HSUVs from the published literature based on the authors' experience. A case study is used to demonstrate some of the features of a systematic HSUV review. Methods are discussed in relation to identifying and selecting the evidence, performing quality and relevance assessment, and undertaking data extraction. It has been developed from a Technical Support Document produced for the National Institute for Health and Clinical Excellence by the Decision Support Unit at the School of Health and Related Research, University of Sheffield.
Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Mesh:

Year:  2013        PMID: 23796303     DOI: 10.1016/j.jval.2013.02.017

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  21 in total

1.  Differences in the Selection of Health State Utility Values by Sponsorship in Published Cost-Effectiveness Analyses.

Authors:  Nathaniel Hendrix; David D Kim; Krishna S Patel; Beth Devine
Journal:  Med Decis Making       Date:  2021-01-15       Impact factor: 2.583

2.  Towards Transparency in the Selection of Published Health Utility Inputs in Cost-Utility Analyses: The Health Utility Application Tool (HAT).

Authors:  Michael J Zoratti; Kelvin K W Chan; Don Husereau; Murray Krahn; Mitchell Levine; Lehana Thabane; Feng Xie
Journal:  Pharmacoeconomics       Date:  2021-06-21       Impact factor: 4.981

Review 3.  Recommended Methods for the Collection of Health State Utility Value Evidence in Clinical Studies.

Authors:  Roberta Ara; John Brazier; Tracey Young
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

Review 4.  The Identification, Review and Synthesis of Health State Utility Values from the Literature.

Authors:  Roberta Ara; John Brazier; Tessa Peasgood; Suzy Paisley
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

5.  Preference-Based Health-Related Quality of Life Outcomes Associated with Preterm Birth: A Systematic Review and Meta-analysis.

Authors:  Stavros Petrou; Natnaree Krabuanrat; Kamran Khan
Journal:  Pharmacoeconomics       Date:  2020-04       Impact factor: 4.981

6.  Tranexamic Acid for Adult Patients with Spontaneous Intracerebral Hemorrhage: A Systematic Review with Meta-analysis.

Authors:  Xing Wang; Lu Ma; Jinlei Song; Chao You
Journal:  CNS Drugs       Date:  2021-10-18       Impact factor: 5.749

7.  A Practical Guide to Conducting a Systematic Review and Meta-analysis of Health State Utility Values.

Authors:  Stavros Petrou; Joseph Kwon; Jason Madan
Journal:  Pharmacoeconomics       Date:  2018-09       Impact factor: 4.981

8.  Health state utility values for diabetic retinopathy: protocol for a systematic review and meta-analysis.

Authors:  Christopher J Sampson; Jonathan C Tosh; Christopher P Cheyne; Deborah Broadbent; Marilyn James
Journal:  Syst Rev       Date:  2015-02-21

9.  Systematic review of health state utility values for acute myeloid leukemia.

Authors:  Anna Forsythe; Patricia S Brandt; Mike Dolph; Sachin Patel; Adrian Paul J Rabe; Gabriel Tremblay
Journal:  Clinicoecon Outcomes Res       Date:  2018-01-25

Review 10.  The impact of acute pneumococcal disease on health state utility values: a systematic review.

Authors:  Ryan O'Reilly; Sayako Yokoyama; Justin Boyle; Jeffrey C Kwong; Allison McGeer; Teresa To; Beate Sander
Journal:  Qual Life Res       Date:  2021-07-17       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.